Literature DB >> 18005134

Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.

Andre Bleich1, John P Sundberg, Anna Smoczek, Reinhard von Wasielewski, Maike F de Buhr, Lydia M Janus, Gwen Julga, Sya N Ukena, Hans-J Hedrich, Florian Gunzer.   

Abstract

Escherichia coli Nissle 1917 (EcN) is a well-characterized probiotic bacterium. Although genomic comparisons of EcN with the uropathogenic E. coli strain CFT073 revealed high degrees of similarity, EcN is generally considered a non-pathogenic organism. However, as recent evidence suggests that EcN is capable of inducing inflammatory responses in host intestinal epithelial cells, we aimed to investigate potential pathogenic properties of EcN in an in vivo model using various germ-free (GF) mouse strains. With the exception of C3H/HeJZtm mice, which carry a defective toll-like receptor (TLR)4-allele, no lesions were obvious in mice of different strains orally inoculated with EcN for 1 week, although organ cultures (blood, lung, mesenteric lymph node, pancreas, spleen, liver and kidney) tested positive to various degrees. C3H/HeJZtm mice inoculated with EcN became clinically ill and the majority died or had to be euthanized. Organs of all gnotobiotic C3H/HeJZtm mice were positive for EcN by culture; major histological findings were moderate to severe pyogranulomatous serositis, typhlitis and pancreatitis. Histological findings were corroborated by highly elevated tumour necrosis factor (TNF) serum levels. Lesions were not detected in specified pathogen free maintained C3H/HeJZtm mice, GF C3H/HeJ mice lacking the interleukin-10 gene, or GF C3H/HeJZtm mice that were inoculated with E. coli K12 strain MG1655 as a control. In addition, mild histological lesions were detected in Ztm:NMRI mice 3 months after oral inoculation with EcN. This study shows that EcN is capable of displaying a virulent phenotype in GF C3H/HeJZtm mice. Whether this phenotype is linked to the bacterium's probiotic nature should be the focus of further studies.

Entities:  

Mesh:

Year:  2007        PMID: 18005134      PMCID: PMC2525753          DOI: 10.1111/j.1365-2613.2007.00560.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  35 in total

1.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Authors:  W J Hopkins; A Gendron-Fitzpatrick; E Balish; D T Uehling
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats.

Authors:  Pedro A Ruiz; Micha Hoffmann; Silke Szcesny; Michael Blaut; Dirk Haller
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.

Authors:  Jibin Sun; Florian Gunzer; Astrid M Westendorf; Jan Buer; Maren Scharfe; Michael Jarek; Frank Gössling; Helmut Blöcker; An-Ping Zeng
Journal:  J Biotechnol       Date:  2005-05-04       Impact factor: 3.307

5.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

6.  Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection.

Authors:  M Wang; K C Jeng; L I Ping
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

7.  TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia.

Authors:  Janet S Lee; Charles W Frevert; Gustavo Matute-Bello; Mark M Wurfel; Venus A Wong; Shu-Min Lin; John Ruzinski; Steve Mongovin; Richard B Goodman; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-07-15       Impact factor: 5.464

8.  Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.

Authors:  Chantal A A Van der Graaf; Mihai G Netea; Servaas A Morré; Martin Den Heijer; Paul E Verweij; Jos W M Van der Meer; Bart Jan Kullberg
Journal:  Eur Cytokine Netw       Date:  2006-03       Impact factor: 2.737

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  11 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.

Authors:  Kerstin Gronbach; Ute Eberle; Martina Müller; Tobias A Olschläger; Ulrich Dobrindt; Frank Leithäuser; Jan Hendrik Niess; Gerd Döring; Jörg Reimann; Ingo B Autenrieth; Julia-Stefanie Frick
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

3.  The Mammalian Microbiome and Its Importance in Laboratory Animal Research.

Authors:  André Bleich; James G Fox
Journal:  ILAR J       Date:  2015

4.  Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.

Authors:  Harshana Sabharwal; Christoph Cichon; Tobias A Ölschläger; Ulrich Sonnenborn; M Alexander Schmidt
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.

Authors:  S Bereswill; A Fischer; I R Dunay; A A Kühl; U B Göbel; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-06-05

6.  Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.

Authors:  Dino Kocijancic; Sebastian Felgner; Michael Frahm; Ronja-Melinda Komoll; Aida Iljazovic; Vinay Pawar; Manfred Rohde; Ulrike Heise; Kurt Zimmermann; Florian Gunzer; Juliane Hammer; Katja Crull; Sara Leschner; Siegfried Weiss
Journal:  Oncotarget       Date:  2016-04-19

7.  Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice.

Authors:  María-José Fábrega; Alba Rodríguez-Nogales; José Garrido-Mesa; Francesca Algieri; Josefa Badía; Rosa Giménez; Julio Gálvez; Laura Baldomà
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

8.  Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine.

Authors:  Rosalie Maltby; Mary P Leatham-Jensen; Terri Gibson; Paul S Cohen; Tyrrell Conway
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

9.  Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

Authors:  Sya N Ukena; Anurag Singh; Ulrike Dringenberg; Regina Engelhardt; Ursula Seidler; Wiebke Hansen; André Bleich; Dunja Bruder; Anke Franzke; Gerhard Rogler; Sebastian Suerbaum; Jan Buer; Florian Gunzer; Astrid M Westendorf
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

10.  Loss of CD14 leads to disturbed epithelial-B cell crosstalk and impairment of the intestinal barrier after E. coli Nissle monoassociation.

Authors:  Marijana Basic; Manuela Buettner; Lydia M Keubler; Anna Smoczek; Inga Bruesch; Stephanie Buchheister; André Bleich
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.